-
1
-
-
33846136090
-
Glutathione-S-transferase genotypes and the adverse effects of azathioprine in young patients with inflammatory bowel disease
-
10.1002/ibd.20004
-
G Stocco S Martelossi A Barabino G Decorti F Bartoli M Montico A Gotti A Ventura 2007 Glutathione-S-transferase genotypes and the adverse effects of azathioprine in young patients with inflammatory bowel disease Inflamm Bowel Dis 13 57 64 10.1002/ibd.20004
-
(2007)
Inflamm Bowel Dis
, vol.13
, pp. 57-64
-
-
Stocco, G.1
Martelossi, S.2
Barabino, A.3
Decorti, G.4
Bartoli, F.5
Montico, M.6
Gotti, A.7
Ventura, A.8
-
2
-
-
10344242983
-
Mutation in the itpa gene predicts intolerance to azathioprine
-
10.1081/NCN-200027639
-
AM Marinaki JA Duley M Arenas A Ansari S Sumi CM Lewis M Shobowale-Bakre LD Fairbanks J Sanderson 2004 Mutation in the itpa gene predicts intolerance to azathioprine Nucleosides Nucleotides Nucleic Acids 23 1393 1397 10.1081/NCN-200027639
-
(2004)
Nucleosides Nucleotides Nucleic Acids
, vol.23
, pp. 1393-1397
-
-
Marinaki, A.M.1
Duley, J.A.2
Arenas, M.3
Ansari, A.4
Sumi, S.5
Lewis, C.M.6
Shobowale-Bakre, M.7
Fairbanks, L.D.8
Sanderson, J.9
-
3
-
-
0031889642
-
Simultaneous determination of 6-thioguanine and methyl 6-mercaptopurine nucleotides of azathioprine in red blood cells by HPLC
-
T Dervieux R Boulieu 1998 Simultaneous determination of 6-thioguanine and methyl 6-mercaptopurine nucleotides of azathioprine in red blood cells by HPLC Clin Chem 44 551 555
-
(1998)
Clin Chem
, vol.44
, pp. 551-555
-
-
Dervieux, T.1
Boulieu, R.2
-
4
-
-
39149120115
-
Azathioprine and 6-mercaptopurine for maintenance of remission in ulcerative colitis
-
CD000478
-
Timmer A, McDonald J, Macdonald J (2007) Azathioprine and 6-mercaptopurine for maintenance of remission in ulcerative colitis. Cochrane Database Syst Rev CD000478
-
(2007)
Cochrane Database Syst Rev
-
-
Timmer, A.1
McDonald, J.2
MacDonald, J.3
-
5
-
-
0035999146
-
Azathioprine in paediatric inflammatory bowel disease: An italian multicentre survey
-
10.1046/j.1365-2036.2002.01269.x
-
A Barabino F Torrente A Ventura S Cucchiara M Castro C Barbera 2002 Azathioprine in paediatric inflammatory bowel disease: an italian multicentre survey Aliment Pharmacol Ther 16 1125 1130 10.1046/j.1365-2036.2002.01269.x
-
(2002)
Aliment Pharmacol Ther
, vol.16
, pp. 1125-1130
-
-
Barabino, A.1
Torrente, F.2
Ventura, A.3
Cucchiara, S.4
Castro, M.5
Barbera, C.6
-
6
-
-
0024554561
-
The purine path to chemotherapy
-
10.1126/science.2649979
-
GB Elion 1989 The purine path to chemotherapy Science 244 41 47 10.1126/science.2649979
-
(1989)
Science
, vol.244
, pp. 41-47
-
-
Elion, G.B.1
-
7
-
-
0034093057
-
Genotypic analysis of thiopurine S-methyltransferase in patients with crohn's disease and severe myelosuppression during azathioprine therapy
-
10.1016/S0016-5085(00)70354-4
-
JF Colombel N Ferrari H Debuysere P Marteau JP Gendre B Bonaz JC Soule R Modigliani Y Touze P Catala C Libersa F Broly 2000 Genotypic analysis of thiopurine S-methyltransferase in patients with crohn's disease and severe myelosuppression during azathioprine therapy Gastroenterology 118 1025 1030 10.1016/S0016-5085(00)70354-4
-
(2000)
Gastroenterology
, vol.118
, pp. 1025-1030
-
-
Colombel, J.F.1
Ferrari, N.2
Debuysere, H.3
Marteau, P.4
Gendre, J.P.5
Bonaz, B.6
Soule, J.C.7
Modigliani, R.8
Touze, Y.9
Catala, P.10
Libersa, C.11
Broly, F.12
-
9
-
-
34547830865
-
Sequential evaluation of thiopurine methyltransferase, inosine triphosphate pyrophosphatase, and hprt1 genes polymorphisms to explain thiopurines' toxicity and efficacy
-
O Palmieri A Latiano F Bossa M Vecchi R D'Inca D Guagnozzi F Tonelli S Cucchiara MR Valvano T Latiano A Andriulli V Annese 2007 Sequential evaluation of thiopurine methyltransferase, inosine triphosphate pyrophosphatase, and hprt1 genes polymorphisms to explain thiopurines' toxicity and efficacy Aliment Pharmacol Ther 26 737 745
-
(2007)
Aliment Pharmacol Ther
, vol.26
, pp. 737-745
-
-
Palmieri, O.1
Latiano, A.2
Bossa, F.3
Vecchi, M.4
D'Inca, R.5
Guagnozzi, D.6
Tonelli, F.7
Cucchiara, S.8
Valvano, M.R.9
Latiano, T.10
Andriulli, A.11
Annese, V.12
-
10
-
-
33947287144
-
Thiopurine treatment in inflammatory bowel disease: Clinical pharmacology and implication of pharmacogenetically guided dosing
-
10.2165/00003088-200746030-00001
-
A Teml E Schaeffeler KR Herrlinger U Klotz M Schwab 2007 Thiopurine treatment in inflammatory bowel disease: clinical pharmacology and implication of pharmacogenetically guided dosing Clin Pharmacokinet 46 187 208 10.2165/00003088-200746030-00001
-
(2007)
Clin Pharmacokinet
, vol.46
, pp. 187-208
-
-
Teml, A.1
Schaeffeler, E.2
Herrlinger, K.R.3
Klotz, U.4
Schwab, M.5
-
11
-
-
0034780344
-
Leucopenia resulting from a drug interaction between azathioprine or 6-mercaptopurine and mesalamine, sulphasalazine, or balsalazide
-
10.1136/gut.49.5.656
-
PW Lowry CL Franklin AL Weaver CL Szumlanski DC Mays EV Loftus WJ Tremaine JJ Lipsky RM Weinshilboum WJ Sandborn 2001 Leucopenia resulting from a drug interaction between azathioprine or 6-mercaptopurine and mesalamine, sulphasalazine, or balsalazide Gut 49 656 664 10.1136/gut.49.5.656
-
(2001)
Gut
, vol.49
, pp. 656-664
-
-
Lowry, P.W.1
Franklin, C.L.2
Weaver, A.L.3
Szumlanski, C.L.4
Mays, D.C.5
Loftus, E.V.6
Tremaine, W.J.7
Lipsky, J.J.8
Weinshilboum, R.M.9
Sandborn, W.J.10
-
12
-
-
33646778817
-
5-aminosalicylate therapy is associated with higher 6-thioguanine levels in adults and children with inflammatory bowel disease in remission on 6-mercaptopurine or azathioprine
-
10.1097/01.MIB.0000206544.05661.9f
-
S Hande N Wilson-Rich A Bousvaros A Zholudev R Maurer P Banks F Makrauer S Reddy R Burakoff S Friedman 2006 5-aminosalicylate therapy is associated with higher 6-thioguanine levels in adults and children with inflammatory bowel disease in remission on 6-mercaptopurine or azathioprine Inflamm Bowel Dis 12 251 257 10.1097/01.MIB.0000206544.05661.9f
-
(2006)
Inflamm Bowel Dis
, vol.12
, pp. 251-257
-
-
Hande, S.1
Wilson-Rich, N.2
Bousvaros, A.3
Zholudev, A.4
Maurer, R.5
Banks, P.6
Makrauer, F.7
Reddy, S.8
Burakoff, R.9
Friedman, S.10
-
13
-
-
36549028729
-
Dose-dependent influence of 5-aminosalicylates on thiopurine metabolism
-
10.1111/j.1572-0241.2007.01511.x
-
NK de Boer DR Wong B Jharap P de Graaf PM Hooymans CJ Mulder F Rijmen LG Engels AA van Bodegraven 2007 Dose-dependent influence of 5-aminosalicylates on thiopurine metabolism Am J Gastroenterol 102 2747 2753 10.1111/j.1572-0241.2007. 01511.x
-
(2007)
Am J Gastroenterol
, vol.102
, pp. 2747-2753
-
-
De Boer, N.K.1
Wong, D.R.2
Jharap, B.3
De Graaf, P.4
Hooymans, P.M.5
Mulder, C.J.6
Rijmen, F.7
Engels, L.G.8
Van Bodegraven, A.A.9
-
14
-
-
18444410760
-
Effects of aminosalicylates on thiopurine S-methyltransferase activity: An ex vivo study in patients with inflammatory bowel disease
-
10.1111/j.1365-2036.2005.02460.x
-
H Xin C Fischer M Schwab U Klotz 2005 Effects of aminosalicylates on thiopurine S-methyltransferase activity: an ex vivo study in patients with inflammatory bowel disease Aliment Pharmacol Ther 21 1105 1109 10.1111/j.1365-2036.2005.02460.x
-
(2005)
Aliment Pharmacol Ther
, vol.21
, pp. 1105-1109
-
-
Xin, H.1
Fischer, C.2
Schwab, M.3
Klotz, U.4
-
16
-
-
0033937522
-
Interaction of 6-mercaptopurine and azathioprine with 5-aminosalicylic acid agents
-
DH Present 2000 Interaction of 6-mercaptopurine and azathioprine with 5-aminosalicylic acid agents Gastroenterology 119 276
-
(2000)
Gastroenterology
, vol.119
, pp. 276
-
-
Present, D.H.1
-
17
-
-
33644873301
-
Tpmt genotype and the use of thiopurines in paediatric inflammatory bowel disease
-
10.1016/j.dld.2005.08.003
-
G Stocco S Martelossi A Barabino M Fontana P Lionetti G Decorti N Malusa F Bartoli M Fezzi T Giraldi A Ventura 2005 Tpmt genotype and the use of thiopurines in paediatric inflammatory bowel disease Dig Liver Dis 37 940 945 10.1016/j.dld.2005.08.003
-
(2005)
Dig Liver Dis
, vol.37
, pp. 940-945
-
-
Stocco, G.1
Martelossi, S.2
Barabino, A.3
Fontana, M.4
Lionetti, P.5
Decorti, G.6
Malusa, N.7
Bartoli, F.8
Fezzi, M.9
Giraldi, T.10
Ventura, A.11
-
18
-
-
33847153405
-
Monitoring of thiopurine methyltransferase activity in postsurgical patients with Crohn's disease during 1 year of treatment with azathioprine or mesalazine
-
10.1097/FTD.0b013e3180312b9a
-
K Dilger E Schaeffeler M Lukas U Strauch H Herfarth R Muller M Schwab 2007 Monitoring of thiopurine methyltransferase activity in postsurgical patients with Crohn's disease during 1 year of treatment with azathioprine or mesalazine Ther Drug Monit 29 1 5 10.1097/FTD.0b013e3180312b9a
-
(2007)
Ther Drug Monit
, vol.29
, pp. 1-5
-
-
Dilger, K.1
Schaeffeler, E.2
Lukas, M.3
Strauch, U.4
Herfarth, H.5
Muller, R.6
Schwab, M.7
-
19
-
-
0036310989
-
N-acetyltransferase 1 and 2 genotypes do not predict response or toxicity to treatment with mesalamine and sulfasalazine in patients with ulcerative colitis
-
10.1111/j.1572-0241.2002.05838.x
-
E Ricart WR Taylor EV Loftus D O'Kane RM Weinshilboum WJ Tremaine WS Harmsen AR Zinsmeister WJ Sandborn 2002 N-acetyltransferase 1 and 2 genotypes do not predict response or toxicity to treatment with mesalamine and sulfasalazine in patients with ulcerative colitis Am J Gastroenterol 97 1763 1768 10.1111/j.1572-0241.2002.05838.x
-
(2002)
Am J Gastroenterol
, vol.97
, pp. 1763-1768
-
-
Ricart, E.1
Taylor, W.R.2
Loftus, E.V.3
O'Kane, D.4
Weinshilboum, R.M.5
Tremaine, W.J.6
Harmsen, W.S.7
Zinsmeister, A.R.8
Sandborn, W.J.9
-
20
-
-
34249946316
-
N-acetyltransferase 2 slow acetylator genotype associated with adverse effects of sulphasalazine in the treatment of inflammatory bowel disease
-
M Chen B Xia B Chen Q Guo J Li M Ye Z Hu 2007 N-acetyltransferase 2 slow acetylator genotype associated with adverse effects of sulphasalazine in the treatment of inflammatory bowel disease Can J Gastroenterol 21 155 158
-
(2007)
Can J Gastroenterol
, vol.21
, pp. 155-158
-
-
Chen, M.1
Xia, B.2
Chen, B.3
Guo, Q.4
Li, J.5
Ye, M.6
Hu, Z.7
|